Speakers Presentations

 

Session 2 - Is it the dawn of a new African healthcare ecosystem: enabling patient engagement and co-creation in UHC 2030

Fatima Seedat, Development Manager, The South African Depression and Anxiety Group - SADAG
Prof Adenike Grange, former Health Minister in Nigeria

 

Session 3 - African patient engagement in the Global Patient Safety Plan 2021-2030

Dr Neda Milevska-Kostova, Vice-Chair, IAPO
Gertrude Avortri, Patient Safety Focal Point, World Health Organization Africa

 

Session 4 - African healthcare innovation: Is there room for patient engagement and co-creation in healthcare innovation?

Padmaja Kamath, Director Regulatory and Scientific Affairs, Global Self-Care Federation

 

Session 5 - African patient engagement in clinical research and development of medicines, vaccines, and health devices

Dr Adeline Edgal, Chief Scientific Officer for SSA, Novartis 

 

Session 6 - Can African health systems advance using personalised healthcare?

Dr Marlene Thomas, Global Patients Affairs, Roche

 

Session 7 - Antimicrobial resistance and Africa. The next pandemic: Are we prepared?

 
 

Session 8 - Health equity in Africa: Neglected Tropical Diseases, entrenched infectious diseases and UN Resolution on Rare Diseases

Samuel Agyei-Wiafe, Executive Director, Rare Disease Initiative Ghana
Dr Roger Sombie, Professor of Hepato-gastroenterology, Yalgado Ouédraogo University Hospital & Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso

 

Session 9 - Have the big four NCD (CVD, Cancer, Diabetes, COPD) vertical programmes overshadowed other NCDs in Africa?

Manan Shah, Vice President, Global Public Affairs, LEO Pharma & Assistant Professor of Public Health, School of Pharmacy & Health Sciences, Fairleigh Dickinson University
Christopher Agbega, Advocacy Officer, Sharecare Ghana
Lefate Makunyane, The South African Depression and Anxiety Group - SADAG
Dr Chandrashekhar Potkar, Chief Medical Officer, Emerging Markets, Viatris

 

Session 10 - Can African UHC 2030 benefit from health technology assessment?

Dr Dalia Dawoud, Scientific Adviser, National Institute for Health and Care Excellence
Mohamed Gad MD, MA, health economist at the Department of Global Health & Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine

 

Session 11 - African Medicines Agency & Reliance

John Mwangi, Co-Chair – Africa Regulatory Network, IFPMA
Mimi Darko, CEO, FDA Ghana
Johnpaul Omollo, Health Research and Development - Program Officer, PATH